Header

UZH-Logo

Maintenance Infos

The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score


Dutkowski, Philipp; Schlegel, Andrea; Slankamenac, Ksenija; Oberkofler, Christian E; Adam, Rene; Burroughs, Andrew K; Schadde, Eric; Müllhaupt, Beat; Clavien, Pierre-Alain (2012). The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Annals of Surgery, 256(5):861-869.

Abstract

OBJECTIVE:
To integrate the amount of hepatic steatosis in modern liver allocation models.
BACKGROUND:
The aim of this study was to combine the 2 largest liver transplant databases (United States and Europe) in 1 comprehensive model to predict outcome after liver transplantation, with a novel focus on the impact of the presence of steatosis in the graft.
METHODS:
We adjusted the balance of risk (BAR) score for its application to the European Liver Transplant Registry (ELTR) database containing 11,942 patients. All liver transplants from ELTR and United Network for Organ Sharing with recorded liver biopsies were then combined in one survival analysis in relation to the presence of graft micro- (n = 9,677) and macrosteatosis (n = 11,516).
RESULTS:
Microsteatosis, regardless of the amount, was associated with a similar relationship between mortality and BAR score as nonsteatotic livers. Low-grade macrosteatotic liver grafts (≤30% macrosteatosis) resulted in 5-year graft-survival rates of 60% or more up to BAR 18, comparable to nonsteatotic grafts. However, use of moderate or severely steatotic liver grafts (>30% macrosteatosis) resulted in acceptable outcome only if the cumulative risk at transplant was low, that is, BAR score of 9 or less.
CONCLUSIONS:
Microsteatotic or 30% or less macrosteatotic liver grafts can be used safely up to BAR score of 18 or less, but liver grafts with more than 30% macrosteatotis should be used with risk adjustment, that is, up to BAR score of 9 or less.

Abstract

OBJECTIVE:
To integrate the amount of hepatic steatosis in modern liver allocation models.
BACKGROUND:
The aim of this study was to combine the 2 largest liver transplant databases (United States and Europe) in 1 comprehensive model to predict outcome after liver transplantation, with a novel focus on the impact of the presence of steatosis in the graft.
METHODS:
We adjusted the balance of risk (BAR) score for its application to the European Liver Transplant Registry (ELTR) database containing 11,942 patients. All liver transplants from ELTR and United Network for Organ Sharing with recorded liver biopsies were then combined in one survival analysis in relation to the presence of graft micro- (n = 9,677) and macrosteatosis (n = 11,516).
RESULTS:
Microsteatosis, regardless of the amount, was associated with a similar relationship between mortality and BAR score as nonsteatotic livers. Low-grade macrosteatotic liver grafts (≤30% macrosteatosis) resulted in 5-year graft-survival rates of 60% or more up to BAR 18, comparable to nonsteatotic grafts. However, use of moderate or severely steatotic liver grafts (>30% macrosteatosis) resulted in acceptable outcome only if the cumulative risk at transplant was low, that is, BAR score of 9 or less.
CONCLUSIONS:
Microsteatotic or 30% or less macrosteatotic liver grafts can be used safely up to BAR score of 18 or less, but liver grafts with more than 30% macrosteatotis should be used with risk adjustment, that is, up to BAR score of 9 or less.

Statistics

Citations

Dimensions.ai Metrics
38 citations in Web of Science®
41 citations in Scopus®
47 citations in Microsoft Academic
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Visceral and Transplantation Surgery
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2012
Deposited On:14 Feb 2013 10:09
Last Modified:17 Feb 2018 00:57
Publisher:Lippincott, Williams & Wilkins
ISSN:0003-4932
OA Status:Closed
Publisher DOI:https://doi.org/10.1097/SLA.0b013e318272dea2
PubMed ID:23095632

Download

Full text not available from this repository.
View at publisher